NMC.L Regulatory News (NMC)

London, 12 October 2015: NMC Health plc (LSE: NMC) ('NMC' or the 'Company'), the leading integrated private healthcare provider operating across the United Arab Emirates and one of the top global providers of fertility treatments through its Spanish subsidiary Clinica Eugin, announces that Mrs Heather Lawrence has given three months' notice of her intention to step down from the NMC Board.

Mrs Lawrence has been a Non-Executive Director of NMC Health plc since March 2012, when she was appointed shortly before the Company's listing onto the premium segment of the London Stock Exchange. Since then she has served on a number of Board Committees including currently the Board's Audit Committee and, since its establishment in June 2013, as Chair of the Board's Clinical Governance Committee. As part of her role on the Clinical Governance Committee, she has focussed with the Committee on reviewing the Group's performance on Clinical matters and the Board's monitoring of this aspect of the Group's business.

Given other demands on her time, Mrs Lawrence has decided to step down from the Board to focus on her other roles, including her role as a Non-Executive Director of Monitor, the NHS Regulator. Mrs Lawrence will cease to be a Director of the Company on 12 January 2016.

Mark Tompkins, Chairman of NMC Health commented:

'The Board would like to thank Heather for her significant contribution over the last three and a half years. Heather has played an important role on the Board since the Company's listing on the premium segment of the London Stock Exchange in April 2012, particularly as Chair of the Clinical Governance Committee which provides Board review of the Group's clinical governance performance. The Board wish her well in her future endeavours.'

Contacts

Investors

NMC

H. J. Mark Tompkins, Chairman

+44 20 3205 7313

Media:

FTI Consulting, London

Matthew Cole

+44 (0)20 3727 1101

FTI Consulting, Gulf

Shane Dolan

+971 (0)4 437 2100

ABOUT NMC HEALTH

NMC Health plc group is the leading private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The Healthcare Division currently operates or manages eight hospitals, two day-care patient centres, nine medical centres and fifteen pharmacies. In addition, the Group owns and operates Clinica Eugin in Barcelona, Spain - one of the leading fertility treatment centres globally. NMC also owns and operates Americare Group, the leading home care provider in the UAE as well as ProVita, the leading provider of long-term medical care, also in the UAE. The enlarged company received almost 2.8m patients in 2014. The group also operates a significant UAE wide Distribution business supplying product lines across several key market segments, including: Pharmaceutical, FMCG, Food and Scientific and Medical Equipment. NMC Health plc group reported revenues of US$ 644m in 2014.

In April 2012 NMC Health plc was listed on the Premium Segment of the London Stock Exchange. At the time of its IPO, the group raised funds to enable it to pursue a further growth plan with a number of capital projects for new healthcare facilities in Abu Dhabi and Dubai. NMC Health plc is a constituent of the FTSE 250 Index.